z-logo
open-access-imgOpen Access
Manifestations of type 2 diabetes in corneal endothelial cell density, corneal thickness and intraocular pressure
Author(s) -
Briggs Stella,
Uchechukwu Levi Osuagwu,
Marie-Anne Essam
Publication year - 2016
Publication title -
journal of biomedical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.617
H-Index - 31
eISSN - 2352-4685
pISSN - 1674-8301
DOI - 10.7555/jbr.30.20140075
Subject(s) - medicine , intraocular pressure , ophthalmology , diabetes mellitus , type 2 diabetes , diabetic retinopathy , treatment modality , ocular hypertension , endocrinology
We sought to evaluate central corneal thickness (CCT), corneal endothelial cell density (ECD) and intraocular\udpressure (IOP) in patients with type 2 diabetes mellitus (DM) and to associate potential differences with diabetes\udduration and treatment modality in a prospective, randomized study. We measured ECD, CCT and IOP of\ud125 patients with type 2 DM (mean age 57.1¡11.5 years) and compared them with 90 age-matched controls.\udMeasured parameters were analyzed for association with diabetes duration and glucose control modalities (insulin\udinjection or oral medication) while controlling for age. In the diabetic group, the mean ECD (2511¡252 cells/mm2),\udmean CCT (539.7¡33.6 mm) and mean IOP (18.3¡2.5 mmHg) varied significantly from those the control group\ud[ECD: 2713¡132 cells/mm2 (P,0.0001), CCT: 525.0¡45.3 mm (P50.003) and IOP: 16.7¡1.8 mmHg\ud(P,0.0001)]. ECD was significantly reduced by about 32 cell/mm2 for diabetics with duration of .10 years when\udcompared with those with duration of ,10 years (P,0.05). CCT was thicker and IOP was higher for diabetics with\udduration of .10 years than those with duration of ,10 years (P.0.05). None of the measured parameters was significantly\udassociated with diabetes duration and treatment modality (P.0.05). In conclusion, subjects with type 2\udDM exhibit significant changes in ECD, IOP and CCT, which, however, are not correlated with disease duration or\udif the patients receive on insulin injection or oral medications

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom